Trending Now
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
Breaking News
Surgical innovation in dry eye disease: Salivary gland transplant
Next-generation IOLs advance complex cataract care
OCT changes with low-level red light therapy for myopia in children
Alcon presenting at APACRS 2025
Breaking News
Popular Now
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis | Ophthalmology Times
Thanks for your interest in this podcast. Please read this important program…
International Glaucoma Symposium highlights the meeting point of practice and technology | Ophthalmology Times
The 2nd International Glaucoma Symposium underscores how AI and advanced imaging are…
MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Ophthalmology Times
(Image Credit: AdobeStock/littlewolf1989) A press release from Mass General Brigham, Boston, reported…
Collaborate With Us
Editor Choice
Itchy Eyelids: Causes, Treatment and Home Remedies
Itchy eyelids, though common, can be a source of significant discomfort and…
Scientist Awarded $300K for AMD Research
Dr. Rajendra Apte, MD, PhD, has been honored with the Research to…
MACUSTAR Extends Systematic AMD Research
The MACUSTAR consortium, led by the Department of Ophthalmology at the University…
FDA Approves XDEMVY for Demodex Blepharitis
Tarsus Pharmaceuticals has received FDA approval for XDEMVY(TM) (lotilaner ophthalmic solution) 0.25%…
Study Finds Key Genes Linked to Primary Open-Angle Glaucoma
In a recent study published in Nature Communications, researchers from Mass Eye…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product…
ESCRS Winter Meeting Starts with Dynamic Program
The European Society of Cataract and Refractive Surgeons (ESCRS) has commenced its…
Opthea Completes Enrollment for Wet AMD Trial
Opthea has reached a significant milestone in its quest to combat wet…
VSY Biotechnology’s 100% Glistening-Free IOL Material
VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge…
Worth Reading
Meeting expectations with evolving technology
Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
Next-generation IOLs advance complex cataract care
Subscribe Now
Enter your email address below and subscribe to our newsletter






















